KRT3 Knockout HeLa Polyclonal Cells represent a CRISPR/Cas9-mediated gene-disrupted polyclonal cell population engineered to ablate expression of the KRT3 gene in the widely used HeLa cervical adenocarcinoma cell line. This loss-of-function model enables systematic investigation of KRT3 biological roles, including its contributions to intermediate filament organization and epithelial cell mechanics, within a well-characterized human cellular context.
The HeLa host cell line, derived from a cervical adenocarcinoma of Henrietta Lacks in 1951, is an immortalized epithelial cell line that retains HPV18 integration and aneuploid chromosome content. Its robust proliferation, ease of genetic manipulation, and extensive characterization make it a foundational platform for cancer biology, virology, and broader biomedical investigations, providing a reproducible background for CRISPR-based functional genomics.
The KRT3 gene encodes a type II cytokeratin that forms obligate heterodimers with KRT12, assembling into intermediate filament networks essential for corneal epithelial structural integrity and transparency. This cytoskeletal system is regulated upstream by transcription factors including PAX6 and KLF4, downstream of EGF receptor and Notch signaling pathways. KRT3 interacts directly with KRT12, as well as with desmosomal components desmoplakin and plakoglobin, and the cytolinker plectin, to anchor filaments at cell?Ccell junctions. Disruption of KRT3 ablates proper filament polymerization, impairing desmosome assembly and compromising cellular responses to mechanical stress, thereby providing a defined system to interrogate keratin filament dynamics and associated intermolecular interactions.
Although KRT3 expression is normally restricted to corneal epithelia, its disruption in HeLa cells eliminates the entire KRT3/KRT12 filament system, offering a clean background to examine type II keratin contributions to intermediate filament network architecture and cell mechanics. The HeLa-derived knockout model enables dissection of KRT3-dependent mechanical stability, desmosome integrity, and signaling cross-talk without confounding corneal-specific differentiation programs, thus providing a versatile platform for mechanistic studies in an accessible, rapidly growing cell line.
Researchers can leverage these polyclonal knockout cells to model Meesmann corneal dystrophy, investigate intermediate filament dynamics, and evaluate pharmacological agents targeting keratin-related pathologies. Typical experimental readouts include western blotting and RT-qPCR for KRT3 and KRT12 expression, immunofluorescence staining of filament networks, co-immunoprecipitation of keratin complexes, and atomic force microscopy for measuring cellular mechanical properties. Additional applications encompass wound healing assays, RNA-seq?Cbased transcriptome profiling, and assessment of desmosome integrity under mechanical challenge. This tool supports advances in epithelial biology and drug discovery. For additional details, please contact Ascent Research.
